{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:44:20Z","timestamp":1782301460844,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2024-2-40910"],"award-info":[{"award-number":["2024-2-40910"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01824-x","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:40:00Z","timestamp":1762875600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-read sequencing analysis of non-classical congenital adrenal hyperplasia prevalence and carrier frequency in Chinese polycystic ovarian syndrome patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"1824_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","volume":"401","author":"MK Auer","year":"2023","unstructured":"Auer MK, Nordenstr\u00f6m A, Lajic S, Reisch N. Congenital adrenal hyperplasia. Lancet. 2023;401:227\u201344.","journal-title":"Lancet"},{"key":"1824_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ecl.2017.01.008","volume":"46","author":"F Hannah-Shmouni","year":"2017","unstructured":"Hannah-Shmouni F, Chen W, Merke DP. Genetics of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. 2017;46:435\u201358.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1824_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.5321","volume":"168","author":"S Gidl\u00f6f","year":"2014","unstructured":"Gidl\u00f6f S, Wedell A, Guthenberg C, von D\u00f6beln U, Nordenstr\u00f6m A. Nationwide neonatal screening for congenital adrenal hyperplasia in Sweden: a 26-year longitudinal prospective population-based study. JAMA Pediatr. 2014;168:567\u201374.","journal-title":"JAMA Pediatr"},{"key":"1824_CR4","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/EJE-18-0712","volume":"180","author":"A Nordenstr\u00f6m","year":"2019","unstructured":"Nordenstr\u00f6m A, Falhammar H. Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency. Eur J Endocrinol. 2019;180:R127\u201345.","journal-title":"Eur J Endocrinol"},{"key":"1824_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1159\/000522260","volume":"96","author":"A Nordenstr\u00f6m","year":"2023","unstructured":"Nordenstr\u00f6m A, Falhammar H, Lajic S. Current and novel treatment strategies in children with congenital adrenal hyperplasia. Horm Res Paediatr. 2023;96:560\u201372.","journal-title":"Horm Res Paediatr"},{"key":"1824_CR6","doi-asserted-by":"crossref","unstructured":"Revised. 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19:41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"1824_CR7","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","volume":"28","author":"R Li","year":"2013","unstructured":"Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28:2562\u20139.","journal-title":"Hum Reprod"},{"key":"1824_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jama.2021.23769","volume":"327","author":"HG Huddleston","year":"2022","unstructured":"Huddleston HG, Dokras A. Diagnosis and treatment of polycystic ovary syndrome. JAMA. 2022;327:274\u20135.","journal-title":"JAMA"},{"key":"1824_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12020-015-0656-0","volume":"50","author":"H Falhammar","year":"2015","unstructured":"Falhammar H, Nordenstr\u00f6m A. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine. 2015;50:32\u201350.","journal-title":"Endocrine"},{"key":"1824_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/humupd\/dmx014","volume":"23","author":"E Carmina","year":"2017","unstructured":"Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Moran C, Oberfield S, et al. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update. 2017;23:580\u201399.","journal-title":"Hum Reprod Update"},{"key":"1824_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110:364\u201379.","journal-title":"Fertil Steril"},{"key":"1824_CR12","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-Hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:4043\u201388.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1909786","volume":"383","author":"DP Merke","year":"2020","unstructured":"Merke DP, Auchus RJ. Congenital adrenal hyperplasia due to 21-Hydroxylase deficiency. N Engl J Med. 2020;383:1248\u201361.","journal-title":"N Engl J Med"},{"key":"1824_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40291-019-00415-z","volume":"23","author":"P Concolino","year":"2019","unstructured":"Concolino P. Issues with the detection of large genomic rearrangements in molecular diagnosis of 21-hydroxylase deficiency. Mol Diagn Ther. 2019;23:563\u20137.","journal-title":"Mol Diagn Ther"},{"key":"1824_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/clinchem\/hvac046","volume":"68","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen M, Liu J, Mao A, Teng Y, Yan H, et al. Comprehensive analysis of congenital adrenal hyperplasia using long-read sequencing. Clin Chem. 2022;68:927\u201339.","journal-title":"Clin Chem"},{"key":"1824_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1210\/clinem\/dgae519","volume":"110","author":"R Wang","year":"2025","unstructured":"Wang R, Luo X, Sun Y, Liang L, Mao A, Lu D, et al. Long-read sequencing solves complex structure of CYP21A2 in a large 21-hydroxylase deficiency cohort. J Clin Endocrinol Metab. 2025;110:406\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117419","volume":"547","author":"H Li","year":"2023","unstructured":"Li H, Zhu X, Yang Y, Wang W, Mao A, Li J, et al. Long-read sequencing: an effective method for genetic analysis of CYP21A2 variation in congenital adrenal hyperplasia. Clin Chim Acta. 2023;547:117419.","journal-title":"Clin Chim Acta"},{"key":"1824_CR18","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jmoldx.2024.05.009","volume":"26","author":"D Yuan","year":"2024","unstructured":"Yuan D, Cai R, Mao A, Tan J, Zhong Q, Zeng D, et al. Improved genetic characterization of congenital adrenal hyperplasia by long-read sequencing compared with multiplex ligation-dependent probe amplification plus Sanger sequencing. J Mol Diagn. 2024;26:770\u201380.","journal-title":"J Mol Diagn"},{"key":"1824_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-238","volume":"13","author":"MJ Chaisson","year":"2012","unstructured":"Chaisson MJ, Tesler G. Mapping single molecule sequencing reads using basic local alignment with successive refinement (BLASR): application and theory. BMC Bioinformatics. 2012;13:238.","journal-title":"BMC Bioinformatics"},{"key":"1824_CR20","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2013;110:2611\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1824_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W. EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur J Hum Genet. 2020;28:1341\u201367.","journal-title":"Eur J Hum Genet"},{"key":"1824_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1824_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023;120:767\u201393.","journal-title":"Fertil Steril"},{"key":"1824_CR24","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91:4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456\u201388.","journal-title":"Fertil Steril"},{"key":"1824_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0015-0282(00)00566-5","volume":"74","author":"J Romaguera","year":"2000","unstructured":"Romaguera J, Moran C, Diaz-Montes TP, Hines GA, Cruz RI, Azziz R. Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. Fertil Steril. 2000;74:59\u201362.","journal-title":"Fertil Steril"},{"key":"1824_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1210\/jcem-58-4-595","volume":"58","author":"RJ Chetkowski","year":"1984","unstructured":"Chetkowski RJ, DeFazio J, Shamonki I, Judd HL, Chang RJ. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab. 1984;58:595\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR28","first-page":"311","volume":"25","author":"C Mor\u00e1n","year":"1994","unstructured":"Mor\u00e1n C, Tapia MC, Hern\u00e1ndez E, V\u00e1zquez G, Garc\u00eda-Hern\u00e1ndez E, Berm\u00fadez JA. Etiological review of hirsutism in 250 patients. Arch Med Res. 1994;25:311\u20134.","journal-title":"Arch Med Res"},{"key":"1824_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJM198507253130404","volume":"313","author":"F Kuttenn","year":"1985","unstructured":"Kuttenn F, Couillin P, Girard F, Billaud L, Vincens M, Boucekkine C, et al. Late-onset adrenal hyperplasia in hirsutism. N Engl J Med. 1985;313:224\u201331.","journal-title":"N Engl J Med"},{"key":"1824_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/jcp.43.6.493","volume":"43","author":"VT Innanen","year":"1990","unstructured":"Innanen VT, Vale JM. Assessment of the one hour adrenocorticotrophic hormone test in the diagnosis of attenuated 21-hydroxylase deficiency. J Clin Pathol. 1990;43:493\u20135.","journal-title":"J Clin Pathol"},{"key":"1824_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1210\/jc.2007-2053","volume":"93","author":"HF Escobar-Morreale","year":"2008","unstructured":"Escobar-Morreale HF, Sanch\u00f3n R, San Mill\u00e1n JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab. 2008;93:527\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR32","first-page":"27","volume":"62","author":"RS Zreik","year":"2014","unstructured":"Zreik RS, Nasrallah MP. The prevalence of endocrinopathies among Lebanese women presenting with hirsutism to an endocrine clinic. J Med Liban. 2014;62:27\u201332.","journal-title":"J Med Liban"},{"key":"1824_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1365-2362.1992.tb01425.x","volume":"22","author":"MA Arnaout","year":"1992","unstructured":"Arnaout MA. Late-onset congenital adrenal hyperplasia in women with hirsutism. Eur J Clin Invest. 1992;22:651\u20138.","journal-title":"Eur J Clin Invest"},{"key":"1824_CR34","first-page":"79","volume":"92","author":"S Khandekar","year":"1990","unstructured":"Khandekar S, Lata V, Dash RJ. Screening for late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Indian J Med Res. 1990;92:79\u201382.","journal-title":"Indian J Med Res"},{"key":"1824_CR35","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1067\/mob.2000.108020","volume":"183","author":"C Moran","year":"2000","unstructured":"Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Iba\u00f1ez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, et al. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol. 2000;183:1468\u201374.","journal-title":"Am J Obstet Gynecol"},{"key":"1824_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0889-8529(08)70017-3","volume":"30","author":"BL Therrell","year":"2001","unstructured":"Therrell BL. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. 2001;30:15\u201330.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1824_CR37","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","volume":"365","author":"DP Merke","year":"2005","unstructured":"Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365:2125\u201336.","journal-title":"Lancet"},{"key":"1824_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06345-1","volume":"23","author":"S Li","year":"2025","unstructured":"Li S, Hua R, Han X, Xu Y, Li M, Gao L, et al. Targeted long-read sequencing facilitates effective carrier screening for complex monogenic diseases including spinal muscular atrophy, \u03b1-\/\u03b2-thalassemia, 21-hydroxylase deficiency, and fragile-X syndrome. J Transl Med. 2025;23:307.","journal-title":"J Transl Med"},{"key":"1824_CR39","doi-asserted-by":"crossref","unstructured":"Robeva R, Andonova S, Todorov T, Feyzullova A, Elenkova A, Kirilov G, Savov A, Zacharieva S, Todorova A. CYP21A2 intron 2 genetic variants might be associated with the clinical characteristics of women with PCOS. Biomedicines. 2024;12:1528.","DOI":"10.3390\/biomedicines12071528"},{"key":"1824_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-021-00280-y","volume":"7","author":"P Hu","year":"2022","unstructured":"Hu P, Tan J, Yu F, Shao B, Zhang F, Zhang J, et al. A capillary electrophoresis-based multiplex PCR assay for expanded carrier screening in the Eastern Han Chinese population. NPJ Genom Med. 2022;7:6.","journal-title":"NPJ Genom Med"},{"key":"1824_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01112-8","volume":"28","author":"Y Fang","year":"2023","unstructured":"Fang Y, Li J, Zhang M, Cheng Y, Wang C, Zhu J. Clinical application value of expanded carrier screening in the population of childbearing age. Eur J Med Res. 2023;28:151.","journal-title":"Eur J Med Res"},{"key":"1824_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/jc.2004-1728","volume":"90","author":"SM Baumgartner-Parzer","year":"2005","unstructured":"Baumgartner-Parzer SM, Nowotny P, Heinze G, Waldh\u00e4usl W, Vierhapper H. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab. 2005;90:775\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR43","first-page":"960","volume":"84","author":"J Fitness","year":"1999","unstructured":"Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, et al. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1999;84:960\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR44","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s40618-023-02093-5","volume":"46","author":"S Polat","year":"2023","unstructured":"Polat S, Karaburgu S, Unluhizarci K, Dundar M, Ozkul Y, Arslan YK, et al. Unexpectedly high mutation rate of cyp11b1 compared to cyp21a2 in randomly-selected Turkish women: a large screening study. J Endocrinol Invest. 2023;46:2367\u201377.","journal-title":"J Endocrinol Invest"},{"key":"1824_CR45","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2265.2006.02521.x","volume":"64","author":"O Admoni","year":"2006","unstructured":"Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype. Clin Endocrinol (Oxf). 2006;64:645\u201351.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1824_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.105554","volume":"198","author":"V Guarnotta","year":"2020","unstructured":"Guarnotta V, Niceta M, Bono M, Marchese S, Fabiano C, Indelicato S, et al. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol. 2020;198:105554.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1824_CR47","first-page":"479","volume":"82","author":"ES Knochenhauer","year":"1997","unstructured":"Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway-Myers BA, Dewailly D, Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab. 1997;82:479\u201385.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0015-0282(99)00317-9","volume":"72","author":"HF Escobar-Morreale","year":"1999","unstructured":"Escobar-Morreale HF, San Mill\u00e1n JL, Smith RR, Sancho J, Witchel SF. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil Steril. 1999;72:629\u201338.","journal-title":"Fertil Steril"},{"issue":"Suppl 5","key":"1824_CR49","first-page":"1315","volume":"13","author":"SF Witchel","year":"2000","unstructured":"Witchel SF, Aston CE. The role of heterozygosity for CYP21 in the polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2000;13(Suppl 5):1315\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1824_CR50","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1210\/jc.2004-1214","volume":"90","author":"D Glintborg","year":"2005","unstructured":"Glintborg D, Hermann AP, Brusgaard K, Hangaard J, Hagen C, Andersen M. Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, Caucasian, hirsute patients compared with healthy controls. J Clin Endocrinol Metab. 2005;90:1347\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"1824_CR51","doi-asserted-by":"crossref","unstructured":"Lidaka L, Bekere L, Lazdane G, Dzivite-Krisane I, Kivite-Urtane A, Gailite L. Non-Classical congenital adrenal Hyperplasia-Causing alleles in adolescent girls with PCOS and in risk group for PCOS development. Diagnostics. 2021;11:980.","DOI":"10.3390\/diagnostics11060980"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01824-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:22:51Z","timestamp":1762881771000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01824-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01824-x","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Peking University Third Hospital (No: M2023387). All the recruited subjects provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the individuals for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}